LIU Lian, MA Ning, MO Da-Peng, et al.. Enterprise Stent in Treatment of Symptomatic Complex Intracranial Atherosclerotic Stenosis[J]. Chinese Journal of Stroke, 2017, 12(07): 592-597.
1 Arenillas JF. Intracranial atherosclerosis:currentconcepts[J]. Stroke,2011,42(1)(suppl):S20-S23.2 Wong KS,Li H. Long-term mortality and recurrentstroke risk among Chinese stroke patients withpredominant intracranial atherosclerosis[J]. Stroke,2003,34(10):2361-2366.3 Kasner SE,Chimowitz MI,Lynn MJ,et al. WarfarinAspirin Symptomatic Intracranial Disease TrialInvestigators. Predictors of ischemic stroke in theterritory of a symptomatic intracranial arterialstenosis[J]. Circulation,2006,113(4):555-563.4 Chimowitz MI,Lynn MJ,Derdeyn CP,et al. Stentingversus aggressive medical therapy for intracranialarterial stenosis[J]. N Engl J Med,2011,365(11):993-1003.5 Zaidat OO,Fitzsimmons BF,Woodward BK,et al.Effect of a balloon-expandable intracranial stent vsmedical therapy on risk of stroke in patients withsymptomatic intracranial stenosis:the VISSITrandomized clinical trial[J]. JAMA,2015,313(12):1240-1248.6 Miao Z,Zhang Y,Shuai J. Study Group of RegistryStudy of Stenting for Symptomatic IntracranialArtery Stenosis in China:Thirty-Day Outcomeof a Multicenter Registry Study of Stenting forSymptomatic Intracranial Artery Stenosis in China[J].Stroke,2015,46(10):2822-2829.7 Wang Y,Miao Z,Wang Y,et al. Protocol for aprospective,multicentre registry study of stenting forsymptomatic intracranial artery stenosis in China[J].BMJ open,2014,4(8):e005175.8 Chimowitz MI,Lynn MJ,Howlett-Smith H,et al.Comparison of warfarin and aspirin for symptomaticintracranial arterial stenosis[J]. N Engl J Med,2005,352(13):1305-1316.9 Bose A,Hartmann M,Henkes H,et al. A novel,self-expanding,nitinol stent in medically refractoryintracranial atherosclerotic stenoses:the Wingspanstudy[J]. Stroke,2007,38(5):1531-1537.10 Zaidat OO,Klucznik R,Alexander MJ,et al. TheNIH registry on use of the Wingspan stent forsymptomatic70-99% intracranial arterial stenosis[J].Neurology,2008,70(17):1518-1524.11 Zhang L,Huang Q,Zhang Y,et al. Wingspan stentsfor the treatment of symptomatic atheroscleroticstenosis in small intracranial vessels:safety andefficacy evaluation[J]. AJNR Am J Neuroradiol,2012,33(2):343-347.12 Liu L,Zhao X,Mo D,et al. Stenting for symptomaticintracranial vertebrobasilar artery stenosis:30-dayresults in a high-volume stroke center[J]. Clin NeurolNeurosurg,2016,143:132-138.13 Silber T,Ziemann U,Ernemann U,et al. Analysisof peri-interventional complications of intracranialangioplasty and stenting:A single centerexperience[J]. Eur J Radiol,2014,83(12):2190-2195.14 Vajda Z,Schmid E,Güthe T,et al. The modifiedBose method for the endovascular treatment ofintracranial atherosclerotic arterial stenoses using theEnterprise stent[J]. Neurosurgery,2012,70(1):91-101.15 Feng Z,Duan G,Zhang P,et al. Enterprise stentfor the treatment of symptomatic intracranialatherosclerotic stenosis:an initial experience of 44patients[J]. BMC Neurol,2015,15(1):1-7.16 Lee KY,Chen DYT,Hsu HL,et al. Undersizedangioplasty and stenting of symptomatic intracranialtight stenosis with Enterprise:Evaluation of clinicaland vascular outcome[J]. Interv Neuroradiol,2015,30(4):325-331.17 Krischek Ö,Miloslavski E,Fischer S,et al. Acomparison of functional and physical properties ofself-expanding intracranial stents [J]. Minim InvasiveNeurosurg,2011,54(1):21-28.18 Gulli G,Marquardt L,Rothwell PM,et al. Stroke riskafter posterior circulation stroke/transient ischemicattack and its relationship to site of vertebrobasilarstenosis pooled data analysis from prospectivestudies[J]. Stroke,2013,44(3):598-604.19 Albuquerque FC,Levy EI,Turk AS,et al.Angiographic patterns of Wingspan in-stentrestenosis[J]. Neurosurgery,2008,63(1):23-27.20 Jiang WJ,Xu XT,Jin M,et al. Apollo stent forsymptomatic atherosclerotic intracranial stenosis:study results[J]. AJNR Am J Neuroradiol,2007,28(5):830-834.21 Schwartz RS,Henry TD. Pathophysiology of coronaryartery restenosis[J]. Rev Cardiovasc Med,2002,3(3suppl):S4-9.22 Fargen KM,Hoh BL,Welch BG,et al. Long-termresults of Enterprise stent-assisted coiling of cerebralaneurysms[J]. Neurosurgery,2012,71(2):239-244.23 Fiorella D,Albuquerque FC,Woo H,et al. Neuroformin-stent stenosis:incidence,natural history,andtreatment strategies[J]. Neurosurgery,2006,59(1):34-42.24 Turk AS,Levy EI,Albuquerque FC,et al. Influenceof patient age and stenosis location on Wingspan instentrestenosis[J]. ANJR,2008,29(1):23-27.25 Lal BK,Beach KW,Roubin GS,et al. Restenosisafter carotid artery stenting and endarterectomy:asecondary analysis of CREST,a randomised controlledtrial[J]. Lancet Neurol,2012,11(9):755-763.
[J]. Chinese Journal of Stroke, 2024, 19(7): 803-808.
[2]
HUO Xiaochuan, LI Xiaoqing, MIAO Zhongrong, Expert Committee for Neurointervention Quality Control of National Center for Healthcare Quality Management in Neurological Diseases, Endovascular Treatment Working Committee of National Action for Quality Improvement of Acute Cerebral Infarction Reperfusion Therapy.
A Survey of Current Practice in Acute Ischemic Stroke Endovascular Treatment in China in 2020
[J]. Chinese Journal of Stroke, 2022, 17(01): 56-65.
[3]
ZHAO Li-Li, LYU Tao, Li Ye,ZHANG Qian, LI Xiao-Hui, JIANG Yu, WANG Hu-Qing, WANG Xiao-Ya, WU Yu-Lun, JIAN Ya-Ting, SUN Man,DANG Mei-Juan, LI Tao, ZHANG Lei, YAO Li, ZHAN Shu-Qin, ZHANG Gui-Lian.
Enterprise Stent for Severe Symptomatic Intracranial Atherosclerotic Stenosis
[J]. Chinese Journal of Stroke, 2020, 15(03): 275-281.